“Diabetic Nephropathy Epidemiology” report has been added to DelveInsight
Overview of Diabetic Nephropathy epidemiology, pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies
Download free sample copy- https://www.delveinsight.com/sample-request/diabetic-nephropathy-epidemiology-forecast
Diabetic Nephropathy Overview
Diabetic nephropathy is a long-term kidney disease that can affect people with diabetes. It is also known as Diabetic Kidney Disease (DKD). It happens when a person’s kidneys are damaged by elevated blood glucose levels.
Diabetic Nephropathy: Geography Covered
Key facts of Diabetic Nephropathy epidemiology report
Diabetic Nephropathy Epidemiology Segmentation
Diabetic Nephropathy Epidemiology Report
Diabetic nephropathy is a leading cause of chronic kidney disease and end-stage renal disease (ESRD). The kidneys in ESRD are no longer able to satisfy the demands of everyday life. Kidney failure can occur as a result of ESRD, which can be life-threatening.
Diabetic Nephropathy Risk Factors
The risk factors for diabetic nephropathy incorporate smoking, comorbidities and is more prevalent in people who are more than 62-65 years old. An individual with diabetic nephropathy may not experience any symptoms in the early stages. Changes in blood pressure and fluid equilibrium in the body, on the other hand, may already be present. Waste products can accumulate in the blood over time, causing symptoms. Swollen feet and ankles, darker urine, shortness of breath are some of the symptoms presented in the later stages.
Diabetic Nephropathy Treatment
The first step in treating diabetic nephropathy is to monitor and manage diabetes, as well as high blood pressure if necessary (hypertension). Kidney disease and other complications may be avoided or delayed with proper blood sugar and hypertension treatment. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) can help to lower blood pressure, protect kidney function, and prevent
Diabetic Nephropathy Prevalent Population
The prevalence of diabetes worldwide has extended epidemic magnitudes and is expected to affect millions of people in the upcoming years. Diabetic nephropathy is the leading cause of chronic kidney disease (CKD) in the United States and other Western societies. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes.
Diabetic Nephropathy Epidemiology: Report Highlights
Following is the TOC of Diabetic Nephropathy epidemiology report
1. Key Insights
2. Executive Summary of Diabetic Nephropathy
3. Diabetic Nephropathy: Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. AboutDelveInsight
What are the reasons to buy this report?
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Vinita Rakheja Email: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: www.delveinsight.com/